Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD)
Authors:
- Young HwangboYHYoung Hwangbo
- Heon-Jeong LeeHLHeon-Jeong Lee
- Yong-Ku KimYKYong-Ku Kim
- 1 December 2008
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 32 (8) , 1824-1828
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: Clinical and therapeutic implicationsMedical Hypotheses, 2007
- Serum neurotrophin concentrations in autism and mental retardation: a pilot studyBrain and Development, 2004
- Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical NeuronsThe Journal of Neuroscience, 2004
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionCell, 2003
- Conditional Deletion Of Brain-Derived Neurotrophic Factor in the Postnatal Brain Leads to Obesity and HyperactivityMolecular Endocrinology, 2001
- Transport of brain-derived neurotrophic factor across the blood–brain barrierNeuropharmacology, 1998
- Neurotrophins Stimulate the Release of Dopamine from Rat Mesencephalic Neurons via Trk and p75Lntr ReceptorsJournal of Biological Chemistry, 1996
- Neurotrophins and Neuronal PlasticityScience, 1995
- Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione SystemJournal of Neurochemistry, 1992
- BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigraNature, 1991